Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Depreciation & Amortization (CF): 2017-2024

Historic Depreciation & Amortization (CF) for Kiniksa Pharmaceuticals International (KNSA) over the last 8 years, with Dec 2024 value amounting to $1.7 million.

  • Kiniksa Pharmaceuticals International's Depreciation & Amortization (CF) fell 3.76% to $384,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 18.96%. This contributed to the annual value of $1.7 million for FY2024, which is 27.60% down from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Depreciation & Amortization (CF) of $1.7 million as of FY2024, which was down 27.60% from $2.3 million recorded in FY2023.
  • Kiniksa Pharmaceuticals International's Depreciation & Amortization (CF)'s 5-year high stood at $2.4 million during FY2020, with a 5-year trough of $1.7 million in FY2024.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Depreciation & Amortization (CF) value was $2.3 million (recorded in 2023), while the average stood at $2.1 million.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Depreciation & Amortization (CF) climbed by 16.30% in 2020 and then dropped by 27.60% in 2024.
  • Kiniksa Pharmaceuticals International's Depreciation & Amortization (CF) (Yearly) stood at $2.4 million in 2020, then decreased by 2.08% to $2.4 million in 2021, then grew by 2.00% to $2.4 million in 2022, then dropped by 2.54% to $2.3 million in 2023, then decreased by 27.60% to $1.7 million in 2024.